Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4091 Target Snapshot

1-deoxy-D-xylulose 5-phosphate reductoisomerase · SINGLE PROTEIN · Escherichia coli K-12

103Compounds
27Assays
0Approved Drugs
117.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P45568. Use UniProt P45568 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P45568 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 1-deoxy-D-xylulose 5-phosphate reductoisomerase as ChEMBL target CHEMBL4091, mapped to UniProt P45568. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
1-deoxy-D-xylulose 5-phosphate reductoisomerase
SINGLE PROTEIN · Escherichia coli K-12
As of 2026-09-14
ChEMBL target ID
CHEMBL4091
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P45568
1-deoxy-D-xylulose 5-phosphate reductoisomerase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 1-deoxy-D-xylulose 5-phosphate reductoisomerase is the right protein anchor across sources, using UniProt P45568 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label1-deoxy-D-xylulose 5-phosphate reductoisomerase
UniProt AccessionP45568
Component TypeProtein
Sequence Length398 aa

1-deoxy-D-xylulose 5-phosphate reductoisomerase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 1-deoxy-D-xylulose 5-phosphate reductoisomerase, mapped to UniProt P45568. Sequence length is 398 aa.

Mapped IDP45568
Review name1-deoxy-D-xylulose 5-phosphate reductoisomerase
OrganismEscherichia coli K-12
Clinical Profile

Clinical Phase Distribution

1
Phase III
Assay Mix

Activity Type Distribution

IC50113.0
KI4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2164257 8.1 IC50 8.0 Preclinical
CHEMBL203125 7.7 IC50 19.95 Clinical
CHEMBL205338 7.55 IC50 28.18 Preclinical
CHEMBL258981 7.32 IC50 48.0 Preclinical
CHEMBL204406 7.3 IC50 50.0 Preclinical
CHEMBL607359 7.27 IC50 53.7 Preclinical
CHEMBL204106 7.23 IC50 59.0 Preclinical
CHEMBL606521 7.19 IC50 64.57 Preclinical
CHEMBL3341763 7.16 IC50 70.0 Preclinical
CHEMBL1651835 7.0 IC50 99.0 Preclinical
Distribution

pChEMBL Value Distribution

21
5.0
10
5.5
10
6.0
16
6.5
13
7.0
9
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

27
Total Assays
91
Tested Compounds
1
Assay Types
Binding — 27 assays, 91 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 27 91 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine